Skip to content
Trouver

Medicine in DR Congo · official US FDA label

Magneque Forte 5g

Sulfate de magnésium (magnesium) · solution injectable

Authorized in DR Congo

Want to buy it?

Not in stock in our pharmacies right now. Trouver shows when it is back near you. The reservation pages are in French.

See the pharmacies

This is a US label.

The official US FDA label for magnesium (published as MAGNESIUM SULFATE), effective September 4, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.

Official US FDA label for magnesium

Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.

Uses

Uses for relief of occasional constipation (irregularity) this product generally produces bowel movement in 1/2 to 6 hours

Dosage

US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.

Directions do not exceed recommended daily dosage drink a full glass (8 ounces) of liquid with each dose may be taken as a single daily dose or in divided doses dissolve the dose in 8 ounces of water. Lemon juice may be added to improve the taste adults and children 12 years and over - 2 to 6 level teaspoons (10 to 30 grams) daily children 6 to under 12 years - 1 to 2 level teaspoons (5 to 10 grams) daily children under 6 years - consult a doctor

Warnings and precautions

Warnings

Side effects

Adverse Reaction Satisfaction guaranteed - Love it or your money back. We welcome any questions you may have at Target.com/comments or 1-800-910-6874. Distributed by Target Corporation Minneapolis, MN 55403 TM & ©2026 TargetBrands, Inc.

Where to find it in DR Congo

Not in stock in our pharmacies right now

Stock changes with every sale. Search by substance: a medicine with the same composition may be available.

Composition

SubstanceStrengthATC code
Sulfate de magnésium (magnesium)5g—

Marketing authorization in DR Congo

From the register of the ACOREP (the Congolese pharmaceutical regulatory authority).

  • Authorization number

    MS.1253/10/05/DGM/1166/2021

    Valid from October 12, 2021 until October 12, 2026

    Holder
    UNIQUE PHARMA Av. Bakongo n° 17, commune de Gombe, ville de Kinshasa, R.D Congo
    Manufacturer
    Biomatrix Healthcare Pvt. Ltd., At: Makcur Laboratories Ltd., 46/4-7, Dehgam Road, Village: Zak, Tal: Dehgam, Dist: Gandhinagar, Gujarat state, INDIA
    Country
    Inde

Sources

  • ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
  • ●English names of substances: RxNorm, U.S. National Library of Medicine.
  • ●Marketing authorizations: register of the ACOREP, DR Congo, version of February 4, 2026.

Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.